| Tag | Content |
|---|
EnhancerAtlas ID | HS193-28731 |
Organism | Homo sapiens |
Tissue/cell | U87 |
Coordinate | chr5:142720470-142722490 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Gfi1b | MA0483.1 | chr5:142720733-142720744 | AAATCACAGCT | + | 6.14 | | HOXA13 | MA0650.2 | chr5:142720588-142720599 | GCCAATAAAAC | + | 6.14 | | MEF2C | MA0497.1 | chr5:142721036-142721051 | AAGACAAAAATAGAA | + | 6.49 | | ZNF263 | MA0528.1 | chr5:142720522-142720543 | TTCTGCTCCTCTCCCTCCTCC | - | 6.21 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_00047 | chr5:142718278-142723685 | Adipose_Nuclei |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr5 | 142721389 | 142721627 | | chr5 | 142721477 | 142721649 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I143341 | chr5 | 142720766 | 142721987 |
|
Enhancer Sequence | CATATTATTT CATCACCCAG ATATTAGGCC CAGTACCCAA TAGTTGTATC TTTTCTGCTC 60
CTCTCCCTCC TCCCACCCTC AGTACCAGGA ATTAAATATG AATAATGAAG GTAGCTCAGC 120
CAATAAAACT GAATCAGTTC TTCAGTCTGT GGGCAAACAC AAAATTCTTC TTTCAGAGGT 180
TTGATAAGCT GTTGTAGTTT CGAAATGATC CAAATAATAA CTTACATGAC TTGATTTATT 240
AAGAAGCCTG AAATATATTA AACAAATCAC AGCTCCAAAG AATGAACAAT AGGATAATGG 300
AATGTTAAAG GAAAACAAAC CAATTTAAAG GAAATTTCCA TCTGCAAAAG GCTTAGTAGG 360
ATCTGCTAAC TCAGAATCAG GAGTGTTCTT TAATTTATGA GGTTCTCATT TCAGTACTTT 420
AAAAAATTAA CGGTAAATGG CCCCATGGCT TATAGCAAAA GGAGACATTC TATTTAAGCA 480
AAGTTATTAG AACAATGGTG ATTGTGAGAA GAGCTGAAAA CAAAAGTCAG TCACTCAGCA 540
ACTAGAATGC CAGAAAGAAA AAAGAAAAGA CAAAAATAGA AATACATCTA CCACTGGTCC 600
TTTCAGGACA TCTGGATACA TGGCTCATAA CTACCCCAAG TAACATCCCT TTCAAACACA 660
AGAAGAGAAG TCTTCTAACT GCCAAAACTG TTCTAACAGA ACATGTGTAT CATATCCTAA 720
TTAGTATTAG CATATTTTTT GACCACCAGA AAGTTGAAAG TGAAATGATG TTATTTAATA 780
TAAACCTGTT CTTAAATAAT ACTTCTCCTA AGAATATTTT TTAGTTATTA AAATAGAATT 840
TTGGGGAAAG AAAAGACCCA CTTCAAATAC TCTGTGGTCA AATATAAAAT TATAATTTAC 900
AACAGATAAT ATATTCAAAT GCCCTCAAAT TTTATTATGA ATTGAACTGA AATATTAGTA 960
CTATGGGCTT AACATCAATA ATTTTATAGC AAAGAAAATA CAGAGAGGGA GGAGGGGCAA 1020
AATGAATGTC TTTTTATCAC ATGTCCTGAC TCACTTCTAC TGGTGCTTGT CCAGGATGAT 1080
GCAATTATTG AATCATAAGC TGTTCCACTG ATGCCATGTT CAAAATGACA AGTCTCAGTC 1140
TCTCAGACTT TCAACAAGAA TCTACGACAG CCACAGTCAA AACAGTATGA ATAACAAAAA 1200
GGTGCCATGC AGGTGTTTCA CAGAAAAAAA AAAACCAAGA AACTATTACA TTTTAAGAAT 1260
TAAAATTTCT TTCCTTCTGG TTACTTCGTT TAGTCTGTTC ATTTTTTATG ATCATACTAT 1320
AATGACGGAG GCTAACTCTT GCTTAGTACG TGGCAGGCAC TATGCCAAAT CATCTACAGG 1380
AATTATCTTG GTTATTTTAA TCTTGGCAAC ATCTCTGAGA ATGGGTTCTA TTAATATCCC 1440
CACTTAAGGG ATAAGGAAAC TGAGGCTTAG AAGGTCTACT GTCCAAGGTC ACCAAGGTGG 1500
TGGCTCTGTG AGAACTGGAA TCTAGATTCT CAGACCTCCA GGGGAGGAGT TTACTCAATG 1560
CATTCTGTTG TTGCTCTCCA TATTGATGAC ATATCAATGA CATTTATTAT GGAAAAACAT 1620
TTGCTGAATC AATTTAAGAG AAGTTGGAAA TGTCAGTAAA AACCTTCATA GCAGTATGAG 1680
AATATGTTTC CAAAAACCAG GAGAAGGAGA TGCCCCAAAA TGTTTTAAGA AGGAATCAGA 1740
AAGTCCTGAG CAAGGAAGCA TCGAAAAATG ATCGAGTTCC TAGCCAGGAG CCAGGAAATG 1800
TGCTTTGTAA TTGGAATTAT AACTGCCCTG AGTAAAACAG ATTGTGTTTT CATGAAGCTT 1860
CAACAGCTCA TTGTAGGAGA CATACAAGGA AAAGGCCAGT TAAAATACAC TGTGATTCAT 1920
GCCGCCATGT GAGAATATCA AAGGACCTTT AGACATAGAG AGGTGTCAGA GAAGTCTTCT 1980
GATTTGCTAC GAGCTGGAAA GGTAAGTAGA GAGGGAAGTC 2020
|
